← Leaderboards
Christopher Sears
Ambergen, Inc
$4,085,467
Attributed
$4,085,467
Total exposure
4
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.5M · FY2007–12$2M$1.5M$1M$500K$0
'07
'08
'09
'10
'11
'12
Funding mix
By agency
NIH$4,085,467 · 4
By mechanism
R44$3,898,292 · 3
R43$187,175 · 1
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Sampling”
- David Divins · Consortium For Ocean Leadership, Inc$609,772,544
- Jeffrey P Krischer · University Of South Florida$522,319,685
- David R. Weir · University Of Michigan At Ann Arbor$421,002,438
- David Heimbrook · Leidos Biomedical Research, Inc.$410,224,927
- Eric S Lander · Whitehead Institute For Biomedical Res$395,613,296
- Richard A Gibbs · Baylor College Of Medicine$356,778,395
Research focus
SamplingBaseEvaluationCostGenesAnticancer ResearchScreening ProcedureTumorDesignRecurrenceQuality Of LifeComputer SoftwareRecommendationNeoplasm MetastasisOntarioBiomarkerCancer RecurrenceInstitutesDropsMortality Vital StatisticsCollectionColorectal CancerCancer PatientMarketing
Grant awards (6)
Expression-Based Multi-Gene Signatures for CRC Recurrence and Chemoselection$999,610
R44 · FY2012 · CA · contact PI
Expression-Based Multi-Gene Signatures for CRC Recurrence and Chemoselection$999,610
R44 · FY2011 · CA · contact PI
Novel Methods for Molecular Analysis of Colorectal Cancer Tissue$524,547
R44 · FY2011 · CA · contact PI
Expression-Based Multi-Gene Signatures for CRC Recurrence and Chemoselection$999,610
R44 · FY2010 · CA · contact PI
A New Approach for the Non-Invasive Detection of Bladder Cancer$187,175
R43 · FY2009 · CA · contact PI
Microarray Assay for Detection of Lab Animal Pathogens$374,915
R44 · FY2007 · AI · contact PI